Cyclic Adenosine Monophosphate-independent Tyrosine Phosphorylation of NR2B Mediates Cocaine-induced Extracellular Signal-regulated Kinase Activation
Overview
Authors
Affiliations
Background: Activation of the extracellular signal-regulated kinase (ERK) in the striatum is crucial for long-term behavioral alterations induced by drugs of abuse. In response to cocaine, ERK phosphorylation (i.e., activation) is restricted to medium-sized spiny neurons expressing dopamine D1 receptor (D1R) and depends on a concomitant stimulation of D1R and glutamate N-methyl-D-aspartate receptor (NMDAR). However, the mechanisms responsible for this activation, especially the respective contribution of D1R and NMDAR, remain unknown.
Methods: We studied striatal neurons in culture stimulated with D1R agonist and/or glutamate and wild-type or genetically modified mice treated with cocaine. Biochemical, immunohistochemical, and imaging studies were performed. Mice were also subjected to behavioral experiments.
Results: Stimulation of D1R cannot activate ERK by itself but potentiates glutamate-mediated calcium influx through NMDAR that is responsible for ERK activation. Potentiation of NMDAR by D1R depends on a cyclic adenosine monophosphate-independent signaling pathway, which involves tyrosine phosphorylation of the NR2B subunit of NMDAR by Src family kinases. We also demonstrate that the D1R/Src family kinases/NR2B pathway is responsible for ERK activation by cocaine in vivo. Inhibition of this pathway abrogates cocaine-induced locomotor sensitization and conditioned place preference.
Conclusions: Our results show that potentiation of NR2B-containing NMDAR by D1R is necessary and sufficient to trigger cocaine-induced ERK activation. They highlight a new cyclic adenosine monophosphate-independent pathway responsible for the integration of dopamine and glutamate signals by the ERK cascade in the striatum and for long-term behavioral alterations induced by cocaine.
Liu X, Lu X, Jiang S, Gao B, Wang P, Zhu H Exp Brain Res. 2024; 243(1):12.
PMID: 39621125 DOI: 10.1007/s00221-024-06969-7.
Reeb K, Wiah S, Patel B, Lewandowski S, Mortensen O, Salvino J Eur J Pharmacol. 2024; 984:177017.
PMID: 39349114 PMC: 11563849. DOI: 10.1016/j.ejphar.2024.177017.
Mao L, Young L, Chu X, Wang J Front Mol Neurosci. 2024; 16:1340725.
PMID: 38273940 PMC: 10808654. DOI: 10.3389/fnmol.2023.1340725.
Gerfen C Front Synaptic Neurosci. 2023; 14:1002960.
PMID: 36741471 PMC: 9892636. DOI: 10.3389/fnsyn.2022.1002960.
Zayed A, Baranowski C, Compagnion A, Vernochet C, Karaki S, Durand-de Cuttoli R Nat Commun. 2022; 13(1):1807.
PMID: 35379786 PMC: 8980038. DOI: 10.1038/s41467-022-29380-8.